Its latest quarterly revenue reached 1.77M, representing a year-over-year decrease of 0.39%, while its net profit experienced a year-over-year decrease of 8.92%.
The current valuation score of InspireMD Inc is 8.38. Its current P/E ratio is -1.09, which is -65.91% below the recent high of -0.37 and -412.73% above the recent low of -5.57.
The current earnings forecast score of InspireMD Inc is 8.00. The average price target is 3.33, with a high of 4.00 and a low of 3.00.
The current price momentum score of InspireMD Inc is 4.26. Currently, the stock price is trading between the resistance level at 0.89 and the support level at 0.68, making it suitable for range-bound swing trading.
The latest institutional shareholding proportion is 49.38%, representing a quarter-over-quarter decrease of 9.65%. The largest institutional shareholder is James Simons, holding a total of 112.83K shares, representing 0.00% of shares outstanding, with 14.84% decrease in holdings.
The current risk assessment score of InspireMD Inc is 3.03. The company's beta value is 0.75. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.